Dr. Vince Clinical Research’s Post

Secure your spot for the upcoming webinar "How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator," sponsored by Cambridge Cognition. Don’t miss this opportunity to learn how cognitive assessment can elevate your clinical trials, boost regulatory success and enhance your product's marketability. Experts from Cambridge Cognition and Dr. Vince Clinical Research will share actionable insights and real-world data crucial for professionals in regulatory affairs, drug development and commercial strategy. Register now: https://lnkd.in/eEnMuhEC #regulatoryaffairs #drugdevelopment #webinar #cognitiveassessment #clinicaltrial #drvinceclinicaltrial #DVCR

Prepare for our upcoming webinar, "Effective Study Design and Execution of Renal and Hepatic Impairment Trials" on November 8th. This session will offer expert guidance for optimizing patient recruitment, designing effective protocols and utilizing advanced pharmacokinetic modeling. Enhance your organ impairment study management strategies with insights from leading professionals at Dr. Vince Clinical Research and Elixia. Reserve your spot today: https://lnkd.in/eFJJXKuS #webinar #renal #hepatic #studydesign #patientcare #clinicalpharmacology #siteselection #registertoday #DVCR #drvinceclinicalresearch

Are you attending the American Society for Pain Management Nursing Conference? Join Lynn Webster, MD, on October 18 for the panel “Awareness of and Participation in Federal and State Policy,” from 8:00AM to 8:50AM CST. Dr. Webster, alongside other industry experts, will explore key updates in federal and state policies affecting pain management, controlled substances and emerging treatments. Don't miss this insightful panel! #ASPMN2024 #ASPMN #painmanagement #substanceabuse #healthcare #DVCR #DrVinceClinicalResearch

DVCR is proud to sponsor the workshop "Clinical Pharmacology Studies on Hepatic and Renal Impairments for NDA Filing: Strategies, Design, Conduct, Analysis and Regulatory Aspects," hosted by the San Francisco Bay chapter of the Pharmaceutical and Bioscience Society. Our team looks forward to presenting insights on conducting these complex studies and connecting with biopharmaceutical professionals from the region. Find the full agenda here: https://lnkd.in/e8CEs3a6 #PBSS #bioscience #pharmacology #clinicalstudies #clinicalresearch #renalimpairment #hepaticimpairment #organimpairment #drvinceclinicalresearch #DVCR

We're #hiring a new Marketing Project Manager in Overland Park, Kansas. Apply today or share this post with your network.

Are you attending the 2024 Pain Therapeutics Summit? Don’t miss Lynn Webster, MD, Executive VP of Scientific Affairs at DVCR, as he presents the optimal methodologies for evaluating a drug’s effect on respiratory drive, which can provide useful data for FDA package inserts and improve safety in clinical practice. Gain valuable insights from an internationally recognized expert in pain and addiction medicine. For more details on Dr. Webster’s presentation, visit the official agenda: https://lnkd.in/ecJBdGxm #PAINTherapeutics #PAINTherapeuticssummit #drugdevelopment #drugeffects #DVCR #DrVinceClinicalResearch

Join us for our upcoming webinar, "Effective Study Design and Execution of Renal and Hepatic Impairment Trials", on November 8th. Gain insights into the critical aspects of renal and hepatic impairment studies, such as effective site selection and management, developing patient-centric protocols, appropriate patient care and oversight and the use of clinical pharmacology tools to inform study design. Register today to secure your place: https://lnkd.in/eUK5xj22 #webinar #renal #hepatic #studydesign #patientcare #clinicalpharmacology #siteselection #registertoday #DVCR #drvinceclinicalresearch

Join us for the webinar "How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator," sponsored by Cambridge Cognition. This session will explore the importance of cognitive assessment as an endpoint in drug development and how it can enhance the value proposition and marketability of new therapeutics. Industry experts from Cambridge Cognition and Dr. Vince Clinical Research will present real-world examples and data-driven insights that are essential for clinical trial designers, regulatory affairs professionals and commercial strategists. Register here: https://lnkd.in/eEnMuhEC #regulatoryaffairs #drugdevelopment #webinar #cognitiveassessment #clinicaltrial #drvinceclinicaltrial #DVCR

We are pleased to announce that Lynn Webster, MD, Executive Vice President of Scientific Affairs at DVCR, will be a panelist at the 2024 American Society for Pain Management Nursing Conference on October 18, 2024. As a Key Opinion Leader in pain management, Dr. Webster will provide in-depth evaluation on the latest federal and state policies surrounding controlled substances. #ASPMN2024 #ASPMN #painmanagement #substanceabuse #healthcare #DVCR #drvinceclinicalresearch #DVCR

Welcome back to “Preskorn’s Perspective.” In this next article, Dr. Preskorn reviewed key principles from the development of six CNS drugs and their implications for future psychiatric treatments. Read about the focused approaches that could shape the next generation of treatments here: https://lnkd.in/eTuNTz95 #psychiatry #neuroscience #neurobiology #innovation #drugdevelopment #centralnervoussystem #clinicalresearch #drvinceclinicalresearch #DVCR